Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.22.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2022
Dec. 31, 2021
Current Assets:    
Cash and cash equivalents $ 32,060,661 $ 40,815,123
Accounts receivable, net 474,471 1,213,195
Inventory, net 1,305,603 1,178,345
Other current assets 1,877,756 1,449,610
Total current assets 35,718,491 44,656,273
Property and equipment, net 2,545,577 1,031,999
Other Assets:    
Goodwill 45,026,583 45,026,583
Intangible assets, net 24,323,246 25,169,489
Long-term equity investment 500,000 500,000
Lease deposits 218,206 218,206
Operating lease right of use assets 3,635,416 836,025
Total other assets 73,703,451 71,750,303
Total assets 111,967,519 117,438,575
Current Liabilities:    
Accounts payable 2,397,898 2,411,085
Operating lease liabilities 861,978 550,525
Accrued expenses and other current liabilities 1,742,467 1,149,907
Deferred revenue 341,469 512,397
Total current liabilities 5,343,812 4,623,914
Long-Term Liabilities:    
Notes payable 300,000 300,000
Accrued interest 39,899 40,152
Operating lease liabilities, net of current 2,732,980 241,677
Total long-term liabilities 3,072,879 581,829
Total liabilities 8,416,691 5,205,743
Commitments and Contingencies (Note 12)
Stockholders’ Equity    
Preferred stock - par value $0.0001; 5,000,000 shares authorized at March 31, 2022 and December 31, 2021, respectively, and none issued or outstanding at March 31, 2022 and December 31, 2021, respectively
Preferred stock, Series A - par value $0.0001; 5,000,000 shares authorized at March 31, 2022 and December 31, 2021, respectively, and none issued or outstanding at March 31, 2022 and December 31, 2021, respectively
Common stock - par value $0.0001; 116,666,667 shares authorized; 40,990,604 issued and outstanding at March 31, 2022 and December 31, 2021, respectively 4,099 4,099
Additional paid in capital 193,830,517 192,502,122
Accumulated deficit (90,283,788) (80,273,389)
Total stockholders’ equity 103,550,828 112,232,832
Total liabilities and stockholders’ equity $ 111,967,519 $ 117,438,575